Glucagon-Like Peptide Receptor Agonists (GLP-1 Receptor agonists): A Powerful Addition to Foundational Therapy Kidney Care in Patients With Type 2 Diabetes Mellitus. Can Diabetes Endocrinol Today 2024, 2 (3), 33–37. https://doi.org/10.58931/cdet.2024.2333.